HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Brown Advisory Inc.

Brown Advisory Inc. reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 7.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,932,930 shares of the company's stock after selling 153,096 shares during the quarter. Brown Advisory Inc. owned 2.23% of HealthEquity worth $170,813,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Proficio Capital Partners LLC purchased a new stake in shares of HealthEquity in the fourth quarter valued at approximately $39,000. Smartleaf Asset Management LLC raised its stake in HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares during the last quarter. Jones Financial Companies Lllp raised its stake in HealthEquity by 1,112.3% in the 4th quarter. Jones Financial Companies Lllp now owns 1,285 shares of the company's stock valued at $123,000 after purchasing an additional 1,179 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in HealthEquity by 2.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock valued at $104,280,000 after purchasing an additional 25,004 shares during the last quarter. Finally, Keybank National Association OH acquired a new position in HealthEquity in the 4th quarter valued at $393,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

NASDAQ:HQY traded down $1.16 during mid-day trading on Wednesday, reaching $101.96. 81,590 shares of the stock were exchanged, compared to its average volume of 861,981. The company has a 50 day simple moving average of $100.43 and a 200-day simple moving average of $98.39. The stock has a market capitalization of $8.82 billion, a P/E ratio of 74.60, a P/E/G ratio of 1.57 and a beta of 0.49. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The firm had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. During the same quarter last year, the business posted $0.80 EPS. Analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This trade represents a 3.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jon Kessler sold 134,183 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.08, for a total value of $15,039,230.64. Following the completion of the sale, the director owned 253,510 shares in the company, valued at approximately $28,413,400.80. This trade represents a 34.61% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

HQY has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, June 5th. Raymond James Financial restated a "strong-buy" rating and issued a $120.00 target price (up from $115.00) on shares of HealthEquity in a report on Tuesday. Barrington Research upped their target price on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a report on Thursday, June 5th. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Finally, KeyCorp dropped their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $118.55.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.